Market Place
Sourcing Support
Vir Bio To Host Q1 2026 Financial Results Call
23 Apr 2026 //
PHARMIWEB
Vir Bio To Host Call On Q4 & Full Year 2025 Financial Results
09 Feb 2026 //
BUSINESSWIRE
Vir Bio To Report Q3 2025 Financial Results On Nov 5, 2025
22 Oct 2025 //
BUSINESSWIRE
Vir Licenses T-Cell Engagers From Sanofi
01 Aug 2024 //
BUSINESSWIRE
Vir Gains T-Cell Engagers From Sanofi, Cuts 25% Staff
01 Aug 2024 //
FIERCE BIOTECH
Vir keeps pressure on Gilead with midphase hepatitis D data
05 Jun 2024 //
FIERCE BIOTECH
Vir`s Hepatitis Delta & B Data Accepted At EASL 2024
22 May 2024 //
BUSINESSWIRE
Vir`s SOLSTICE Data Featured At EASL 2024
21 May 2024 //
BUSINESSWIRE
Vir Provides Corporate Update, Q1 2024 Financial Results
02 May 2024 //
BUSINESSWIRE
Vir Biotechnology to Participate in BofA Healthcare Conference
30 Apr 2024 //
BUSINESSWIRE
How Vir found the one: CEO Marianne De Backer
19 Apr 2024 //
FIERCE BIOTECH
Vir Business Update, Q1 2024 Results On 5/2
11 Apr 2024 //
BUSINESSWIRE
Vir Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial
05 Mar 2024 //
BUSINESSWIRE
GSK, Vir end flu drug alliance, removing key piece of $345M pact
23 Feb 2024 //
FIERCE BIOTECH
Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
23 Feb 2024 //
BUSINESSWIRE
Vir Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results
22 Feb 2024 //
BUSINESSWIRE
Vir Biotechnology to Report Fourth Quarter 2023 Financial Results
01 Feb 2024 //
PRESS RELEASE
Vir downsizes by 12%, will close St. Louis and Portland sites in 2024
13 Dec 2023 //
ENDPTS
Vir to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B
10 Nov 2023 //
BUSINESSWIRE
Vir Biotechnology Reports Third Quarter 2023 Financial Results
02 Nov 2023 //
BUSINESSWIRE
Post-pandemic & flush with cash, Vir eyes frontiers in oncology and neurology
30 Oct 2023 //
ENDPTS
Vir Bio to Participate in the H.C. Wainwright 4th Annual HBV Conference
12 Oct 2023 //
GLOBENEWSWIRE
Vir Bio Announces Multiple Abstracts Highlighting New Chronic Hepatitis B
11 Oct 2023 //
GLOBENEWSWIRE
Vir Biotechnology to Report Third Quarter 2023 Financial Results
05 Oct 2023 //
GLOBENEWSWIRE
Vir Awarded BARDA Funding to Support Development of Antibody Platform
03 Oct 2023 //
GLOBENEWSWIRE
Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
29 Aug 2023 //
GLOBENEWSWIRE
New Vir CEO drops small molecules to `judiciously` use cash pile
04 Aug 2023 //
FIERCE BIOTECH
Vir Reports Second Quarter 2023 Financial Results
03 Aug 2023 //
GLOBENEWSWIRE
Vir Biotechnology to Report Q2 2023 Financial Results on August 3, 2023
26 Jul 2023 //
GLOBENEWSWIRE
Vir Announces Abstracts Showing Hepatitis B and D Data Accepted for Presentation
07 Jun 2023 //
GLOBENEWSWIRE
Vir to Participate in the 44th Annual Goldman Sachs Global Healthcare Conference
05 Jun 2023 //
GLOBENEWSWIRE
Vir Announces First Patient Dosed in New Phase 2 Chronic Hepatitis B Virus Trial
11 May 2023 //
GLOBENEWSWIRE
Vir Biotechnology to Participate in the BofA Securities 2023 Health Conference
03 May 2023 //
GLOBENEWSWIRE
Vir to Participate in the 22nd Annual Needham Virtual Healthcare Conference
11 Apr 2023 //
GLOBENEWSWIRE
Vir Biotechnology to Participate in Cowen 43rd Annual Health Care Conference
28 Feb 2023 //
GLOBENEWSWIRE
MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference
28 Feb 2023 //
GLOBENEWSWIRE
Vir Biotechnology Reports Fourth Quarter and Full Year 2022 Financial Results
23 Feb 2023 //
GLOBENEWSWIRE
Vir Announces Positive Final Draft Guidance on Sotrovimab from the NICE
22 Feb 2023 //
GLOBENEWSWIRE
Vir Biotechnology to Report Fourth Quarter and Full Year 2022 Financial Results
16 Feb 2023 //
PRESS RELEASE
Vir Biotechnology Appoints Sung Lee as Chief Financial Officer
16 Feb 2023 //
GLOBENEWSWIRE
Vir Biotechnology Announces Retirement of CEO George Scangos
25 Jan 2023 //
GLOBENEWSWIRE
Vir taps Bayer dealmaker De Backer as its next CEO
25 Jan 2023 //
FIERCE PHARMA
Vir Biotechnology Achieves Target Enrollment for Groundbreaking Ph2 PENINSULA
21 Dec 2022 //
GLOBENEWSWIRE
Vir Biotech Ranked the Fastest-Growing Company in North America on the 2022
16 Nov 2022 //
GLOBENEWSWIRE
Vir Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434
06 Nov 2022 //
PRESS RELEASE
Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218
06 Nov 2022 //
GLOBENEWSWIRE
Vir Biotechnology Provides Corporate Update and Reports 3Q FYR
03 Nov 2022 //
GLOBENEWSWIRE
Vir Announces Abstracts Highlighting Hepatitis B Data Accepted for Presentation
31 Oct 2022 //
GLOBENEWSWIRE
Vir Biotechnology to Provide Corporate Update &Report 3QR 2022 Financial Results
28 Oct 2022 //
GLOBENEWSWIRE
Vir Announces First Patient Dosed in Phase 2 Trial of VIR-2482
18 Oct 2022 //
GLOBENEWSWIRE
Vir Biotechnology to Participate in the H. C. Wainwright 3rd Annual Hepatitis B
11 Oct 2022 //
GLOBENEWSWIRE
Vir Biotechnology Awarded U.S. Govtt Contract to Support Pandemic Preparedness
04 Oct 2022 //
GLOBENEWSWIRE
Covid Drugmaker Vir Wins US Pandemic Contract Worth Up to $1 Billion
04 Oct 2022 //
BLOOMBERG
Vir Announces First Patient Dosed in the PII Evaluating VIR-2218 & VIR-3434
23 Sep 2022 //
GLOBENEWSWIRE
Vir Biotechnology Reports Second Quarter 2022 Financial Results
09 Aug 2022 //
GLOBENEWSWIRE
Xencor Reports Second Quarter 2022 Financial Results
03 Aug 2022 //
BUSINESSWIRE
Vir Biotechnology to Provide Corporate Update and Report Second Q202
21 Jul 2022 //
GLOBENEWSWIRE
Vir Biotechnology Announces Transition of Chief Scientific Officer
14 Jul 2022 //
GLOBENEWSWIRE
Brii Bio Exercises Option for Vir`s VIR-3434 Targeting Hepatitis B
04 Jul 2022 //
ASIAONE
Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program
25 Jun 2022 //
GLOBENEWSWIRE
